Meng Q, Li Z, He X, Hu Y, Wu G, Huang J
Front Pharmacol. 2025; 16:1496511.
PMID: 39989901
PMC: 11842333.
DOI: 10.3389/fphar.2025.1496511.
Famta P, Shah S, Dey B, Kumar K, Bagasariya D, Vambhurkar G
Cancer Pathog Ther. 2025; 3(1):30-47.
PMID: 39872366
PMC: 11764040.
DOI: 10.1016/j.cpt.2024.01.001.
Zu F, Chen C, Geng Q, Li H, Chan B, Luo G
Int J Biol Sci. 2025; 21(2):524-543.
PMID: 39781447
PMC: 11705628.
DOI: 10.7150/ijbs.102381.
Choi J, Seok H, Lee D, Kwon J, Shin U, Shin I
J Transl Med. 2024; 22(1):980.
PMID: 39472937
PMC: 11523791.
DOI: 10.1186/s12967-024-05797-1.
Li Z, Qin C, Zhao B, Li T, Zhao Y, Zhang X
Ther Adv Med Oncol. 2024; 16:17588359241284935.
PMID: 39421679
PMC: 11483845.
DOI: 10.1177/17588359241284935.
Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition.
Schwab A, Rao Z, Zhang J, Gollowitzer A, Siebenkas K, Bindel N
Nat Cell Biol. 2024; 26(9):1470-1481.
PMID: 39009641
PMC: 11392809.
DOI: 10.1038/s41556-024-01464-1.
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.
Ferreres J, Vinyals A, Campos-Martin R, Espin R, Podlipnik S, Ramos R
Mol Oncol. 2024; 18(10):2471-2494.
PMID: 38978350
PMC: 11459042.
DOI: 10.1002/1878-0261.13688.
Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y
Signal Transduct Target Ther. 2024; 9(1):132.
PMID: 38763973
PMC: 11102923.
DOI: 10.1038/s41392-024-01823-2.
Switch of ELF3 and ATF4 transcriptional axis programs the amino acid insufficiency-linked epithelial-to-mesenchymal transition.
Lin J, Hou L, Zhao X, Zhong J, Lv Y, Jiang X
Mol Ther. 2024; 32(6):1956-1969.
PMID: 38627967
PMC: 11184330.
DOI: 10.1016/j.ymthe.2024.04.025.
Crosstalk between lipid metabolism and EMT: emerging mechanisms and cancer therapy.
Din Z, Cui B, Wang C, Zhang X, Mehmood A, Peng F
Mol Cell Biochem. 2024; 480(1):103-118.
PMID: 38622439
DOI: 10.1007/s11010-024-04995-1.
METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis.
Ouyang P, Li K, Xu W, Chen C, Shi Y, Tian Y
J Exp Clin Cancer Res. 2024; 43(1):111.
PMID: 38605400
PMC: 11007974.
DOI: 10.1186/s13046-024-03035-6.
Advances in tumor microenvironment and underlying molecular mechanisms of bladder cancer: a systematic review.
Tang L, Xu H, Wu T, Wu W, Lu Y, Gu J
Discov Oncol. 2024; 15(1):111.
PMID: 38602556
PMC: 11009183.
DOI: 10.1007/s12672-024-00902-8.
SALL4 in gastrointestinal tract cancers: upstream and downstream regulatory mechanisms.
Wang T, Jin Y, Wang M, Chen B, Sun J, Zhang J
Mol Med. 2024; 30(1):46.
PMID: 38584262
PMC: 11000312.
DOI: 10.1186/s10020-024-00812-z.
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B, Sajeev A, Vishwa R, Aswani B, AlQahtani M, Abbas M
Cancer Metastasis Rev. 2024; 43(1):321-362.
PMID: 38517618
DOI: 10.1007/s10555-024-10171-0.
TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
Ren J, Chen X, Li J, Zan Y, Wang S, Tan Y
Epigenetics. 2024; 19(1):2323751.
PMID: 38431880
PMC: 10913696.
DOI: 10.1080/15592294.2024.2323751.
PKM2 promotes lymphatic metastasis of hypopharyngeal carcinoma via regulating epithelial-mesenchymal transition: an experimental research.
Zhou X, Li Y, Pan M, Lu T, Liu C, Wang Z
Diagn Pathol. 2024; 19(1):48.
PMID: 38431604
PMC: 10907999.
DOI: 10.1186/s13000-024-01474-5.
TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT.
Chen X, Zhou Z, Tang P, Du F, Wang S, Yao J
Curr Cancer Drug Targets. 2024; 25(1):72-82.
PMID: 38415469
PMC: 11826914.
DOI: 10.2174/0115680096281231240202073558.
K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3.
Geissert R, Lammert A, Wirth S, Honig R, Lohfink D, Unger M
Cell Commun Signal. 2024; 22(1):85.
PMID: 38291468
PMC: 10826106.
DOI: 10.1186/s12964-024-01484-2.
Evaluation of the Therapeutic Effects of Harmine on Anaplastic Thyroid Cancer Cells.
Baldini E, Cardarelli S, Campese A, Lori E, Fallahi P, Virili C
Int J Mol Sci. 2024; 25(2).
PMID: 38256193
PMC: 10816100.
DOI: 10.3390/ijms25021121.
HuR (ELAVL1) Stabilizes mRNA and Promotes Migration and Invasion in Breast Cancer Cells.
Morillo-Bernal J, Pizarro-Garcia P, Moreno-Bueno G, Cano A, Mazon M, Eraso P
Cancers (Basel). 2024; 16(2).
PMID: 38254873
PMC: 10813878.
DOI: 10.3390/cancers16020384.